JENNIFER BENDOKAS: Open Payments
NPI 1396155206 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,045 in 33 payments from 9 companies in 2025. Trend: 2023 $44 · 2024 $919 · 2025 $2,045
Food & beverage: $2,045
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 10 | $510 |
| Amgen Inc. | 3 | $379 |
| Regeneron Healthcare Solutions, Inc. | 6 | $323 |
| GENZYME CORPORATION | 5 | $238 |
| Optinose US, Inc. | 5 | $190 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $146 |
| AERIN MEDICAL INC. | 1 | $140 |
| GlaxoSmithKline, LLC. | 1 | $60 |
| Smith+Nephew, Inc. | 1 | $59 |
Products named: DUPIXENT, INSPIRE, KRYSTEXXA, Xhance, LUMRYZ, VIVAER STYLUS, REPATHA, NUCALA.
Industry payments across VA — which companies pay providers there.
